Hynic-toc

• Description:

  Hynic-toc (HYNIC-Tyr3-octreotide), a octreotide derivative, can be conjugated with radioactive element for tumor imaging[1]. Hynic-toc can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .

• Product Name Alternative:

  HYNIC-Tyr3-octreotide

• UNSPSC:

  12352209

• Target:

  Radionuclide-Drug Conjugates (RDCs)

• Type:

  Peptides

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/hynic-toc.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@H](CO)[C@H](O)C)=O)NC([C@H](NC(C(C=C/2)=CNC2=N\N)=O)CC3=CC=CC=C3)=O)=O)CC4=CC=C(C=C4)O)N[C@@H]1CC5=CNC6=CC=CC=C56

• Molecular Formula:

  C55H71N13O12S2

• Molecular Weight:

  1170.36

• References & Citations:

  [1]Decristoforo C, et al. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med. 2000 Sep;27 (9) :1318-25.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  [257943-19-4]